EMRIX
Price
$14.48
Change
+$0.20 (+1.40%)
Updated
Jan 30 closing price
Net Assets
396.24M
VEMAX
Price
$37.12
Change
+$0.41 (+1.12%)
Updated
Jan 30 closing price
Net Assets
108.96B
Ad is loading...

EMRIX vs VEMAX

Header iconEMRIX vs VEMAX Comparison
Open Charts EMRIX vs VEMAXBanner chart's image
VanEck Emerging Markets I
Price$14.48
Change+$0.20 (+1.40%)
VolumeN/A
Net Assets396.24M
Vanguard Emerging Mkts Stock Idx Adm
Price$37.12
Change+$0.41 (+1.12%)
VolumeN/A
Net Assets108.96B
EMRIX vs VEMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
EMRIX vs. VEMAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EMRIX is a StrongBuy and VEMAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VEMAX has more cash in the bank: 109B vs. EMRIX (396M). VEMAX pays higher dividends than EMRIX: VEMAX (3.43) vs EMRIX (1.58). EMRIX was incepted earlier than VEMAX: EMRIX (17 years) vs VEMAX (19 years). EMRIX is a more actively managed with annual turnover of: 11.00 vs. VEMAX (5.00). VEMAX has a lower initial minimum investment than EMRIX: VEMAX (3000) vs EMRIX (1000000). VEMAX annual gain was more profitable for investors over the last year : 13.85 vs. EMRIX (6.29). VEMAX return over 5 years is better than : 15.47 vs. EMRIX (-15.41).
EMRIXVEMAXEMRIX / VEMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence17 years19 years-
Gain YTD2.550-0.163-1,562%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets396M109B0%
Annual Yield % from dividends1.583.4346%
Returns for 1 year6.2913.8545%
Returns for 3 years-9.00-4.03223%
Returns for 5 years-15.4115.47-100%
Returns for 10 years8.8529.0330%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNVS3.660.16
+4.57%
Cineverse Corp
SABR3.390.08
+2.42%
Sabre Corp
PTCT46.150.93
+2.06%
PTC Therapeutics
OPRX5.710.05
+0.88%
OptimizeRx Corp
K81.940.17
+0.21%
Kellanova